Molecular Partners Ag Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 10.29M10.63M196.81M7.93M5.65M
Operating items
Research & Development 52.68M55.00M55.25M
Selling, General & Administrative 23.08M21.83M19.99M
Other Operating Expenses 12.83M18.98M
Operating Expenses 12.83M18.98M75.76M76.82M75.23M
Operating Income 121.05M-68.89M-69.59M
EBIT 121.05M-68.89M-69.59M
Non-operating items
Interest & Investment Income 1.93M4.82M8.20M
Non Operating Income 1.29M-0.99M8.16M
Net income details
EBT 122.33M-69.88M-61.43M
Tax Provisions 0.00M
Profit After Tax 171.97M168.61M122.33M-69.88M-61.43M
Income from Continuing Operations 122.33M-69.88M-61.43M
Consolidated Net Income 122.33M-69.88M-61.43M
Income towards Parent Company 122.33M-69.88M-61.43M
Net Income towards Common Stockholders 122.33M-69.88M-61.43M
Additional items
EPS (Basic) 3.77-2.13-1.81
EPS (Weighted Average and Diluted) 3.67-2.13-1.81
Shares Outstanding (Weighted Average) 32.16M32.16M32.51M32.84M33.19M
EBITDA 121.05M-68.89M-69.59M
Interest Expenses 0.64M5.81M0.04M